Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 20 of 144

1.

Therapeutic Strategies for Targeting IL-33/ST2 Signalling for the Treatment of Inflammatory Diseases.

Chen WY, Tsai TH, Yang JL, Li LC.

Cell Physiol Biochem. 2018;49(1):349-358. doi: 10.1159/000492885. Epub 2018 Aug 23. Review.

2.

Generation, Characteristics and Clinical Trials of Ex Vivo Generated Tolerogenic Dendritic Cells.

Kim SH, Jung HH, Lee CK.

Yonsei Med J. 2018 Sep;59(7):807-815. doi: 10.3349/ymj.2018.59.7.807. Review.

3.

Value of anti-plasminogen binding peptide, anti-carbonic anhydrase II, immunoglobulin G4, and other serological markers for the differentiation of autoimmune pancreatitis and pancreatic cancer.

Detlefsen S, de Vos JD, Tanassi JT, Heegaard NHH, Fristrup C, Schaffalitzky de Muckadell OB.

Medicine (Baltimore). 2018 Aug;97(31):e11641. doi: 10.1097/MD.0000000000011641.

4.

Altered Function of Antigen-Presenting Cells in Type 1 Diabetes: A Challenge for Antigen-Specific Immunotherapy?

Creusot RJ, Postigo-Fernandez J, Teteloshvili N.

Diabetes. 2018 Aug;67(8):1481-1494. doi: 10.2337/db17-1564. Review.

PMID:
30030289
5.

Association of serum/plasma high mobility group box 1 with autoimmune diseases: A systematic review and meta-analysis.

Zhu B, Zhu Q, Li N, Wu T, Liu S, Liu S.

Medicine (Baltimore). 2018 Jul;97(29):e11531. doi: 10.1097/MD.0000000000011531. Review.

6.

Support of precision medicine through risk-stratification in autoimmune liver diseases - histology, scoring systems, and non-invasive markers.

Bossen L, Gerussi A, Lygoura V, Mells GF, Carbone M, Invernizzi P.

Autoimmun Rev. 2018 Sep;17(9):854-865. doi: 10.1016/j.autrev.2018.02.013. Epub 2018 Jul 11. Review.

PMID:
30005861
7.

Efficacy and patient satisfaction in the use of subcutaneous immunoglobulin immunotherapy for the treatment of auto-immune neuromuscular diseases.

Sala TP, Crave JC, Duracinsky M, Lepira Bompeka F, Tadmouri A, Chassany O, Cherin P.

Autoimmun Rev. 2018 Sep;17(9):873-881. doi: 10.1016/j.autrev.2018.03.010. Epub 2018 Jul 10. Review.

PMID:
30005853
8.

Physiological effects of modulating the interleukin-6 axis.

Schett G.

Rheumatology (Oxford). 2018 Feb 1;57(suppl_2):ii43-ii50. doi: 10.1093/rheumatology/kex513. Review.

PMID:
29982781
9.

Crosstalk between metabolism and epigenetic modifications in autoimmune diseases: a comprehensive overview.

Wang Z, Long H, Chang C, Zhao M, Lu Q.

Cell Mol Life Sci. 2018 Sep;75(18):3353-3369. doi: 10.1007/s00018-018-2864-2. Epub 2018 Jul 4. Review.

PMID:
29974127
10.

Humanized Mouse Model to Study Type 1 Diabetes.

Luce S, Guinoiseau S, Gadault A, Letourneur F, Blondeau B, Nitschke P, Pasmant E, Vidaud M, Lemonnier F, Boitard C.

Diabetes. 2018 Sep;67(9):1816-1829. doi: 10.2337/db18-0202. Epub 2018 Jul 2.

PMID:
29967002
11.

Loss of IDO1 Expression From Human Pancreatic β-Cells Precedes Their Destruction During the Development of Type 1 Diabetes.

Anquetil F, Mondanelli G, Gonzalez N, Rodriguez Calvo T, Zapardiel Gonzalo J, Krogvold L, Dahl-Jørgensen K, Van den Eynde B, Orabona C, Grohmann U, von Herrath MG.

Diabetes. 2018 Sep;67(9):1858-1866. doi: 10.2337/db17-1281. Epub 2018 Jun 26.

PMID:
29945890
12.

Collateral Damage: Insulin-Dependent Diabetes Induced With Checkpoint Inhibitors.

Stamatouli AM, Quandt Z, Perdigoto AL, Clark PL, Kluger H, Weiss SA, Gettinger S, Sznol M, Young A, Rushakoff R, Lee J, Bluestone JA, Anderson M, Herold KC.

Diabetes. 2018 Aug;67(8):1471-1480. doi: 10.2337/dbi18-0002. Epub 2018 Jun 24. Review.

13.

IgG4-related disease: review of the histopathologic features, differential diagnosis, and therapeutic approach.

Bledsoe JR, Della-Torre E, Rovati L, Deshpande V.

APMIS. 2018 Jun;126(6):459-476. doi: 10.1111/apm.12845. Review.

PMID:
29924455
14.

Association of Stress-Related Disorders With Subsequent Autoimmune Disease.

Song H, Fang F, Tomasson G, Arnberg FK, Mataix-Cols D, Fernández de la Cruz L, Almqvist C, Fall K, Valdimarsdóttir UA.

JAMA. 2018 Jun 19;319(23):2388-2400. doi: 10.1001/jama.2018.7028.

PMID:
29922828
15.

Intratympanic gadolinium magnetic resonance imaging supports the role of endolymphatic hydrops in the pathogenesis of immune-mediated inner-ear disease.

Lobo D, Tuñón M, Villarreal I, Brea B, García-Berrocal JR.

J Laryngol Otol. 2018 Jun;132(6):554-559. doi: 10.1017/S0022215118000749. Epub 2018 Jun 11.

PMID:
29888688
16.

Impact of obesity on autoimmune arthritis and its cardiovascular complications.

Van Raemdonck K, Umar S, Szekanecz Z, Zomorrodi RK, Shahrara S.

Autoimmun Rev. 2018 Aug;17(8):821-835. doi: 10.1016/j.autrev.2018.02.007. Epub 2018 Jun 6. Review.

PMID:
29885537
17.

Salivary Gland Pathology in IgG4-Related Disease: A Comprehensive Review.

Puxeddu I, Capecchi R, Carta F, Tavoni AG, Migliorini P, Puxeddu R.

J Immunol Res. 2018 Apr 1;2018:6936727. doi: 10.1155/2018/6936727. eCollection 2018. Review.

19.

Immune Recognition of β-Cells: Neoepitopes as Key Players in the Loss of Tolerance.

James EA, Pietropaolo M, Mamula MJ.

Diabetes. 2018 Jun;67(6):1035-1042. doi: 10.2337/dbi17-0030. Review.

PMID:
29784651
20.

IgG4-related disease of pulmonary artery causing pulmonary hypertension.

Deng H, Zhao S, Yue Y, Liu Y, Xu Y, Qian J, Ma X, Gao P, Yao X, Jiang X, Xu X, Jing Z, Wang Y, Pan L, Xue X.

Medicine (Baltimore). 2018 May;97(20):e10698. doi: 10.1097/MD.0000000000010698.

Supplemental Content

Loading ...
Support Center